SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : MLSC Blood decontaminant recieves patent!!!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cindy Powell who wrote (97)5/6/1997 8:57:00 AM
From: Zencone   of 196
 
Medical Discoveries Names Lee F. Kulas President and CEO

SALT LAKE CITY, May 6 /PRNewswire/ -- Medical Discoveries, Inc. (OTC:BB - news) announced today that Lee F. Kulas, has been named president and chief executive officer of the company. Kulas has over 20 years of broad-based experience in management, marketing, sales and international business development, and has served as chief executive of two medical device start-up companies. He was most recently associated with K.K. Adachi (Osaka, Japan) as president and chief
executive officer of Adachi's U.S. operations. Founder and former CEO of Applied Vascular Engineering, Inc. (Nasdaq:AVEI - news), Kulas has also held marketing and sales positions with the Cordis Corporation (now a division of Johnson & Johnson), Mallinckrodt Interventional Cardiology, the Puritan Bennett Corp. and C.R. Bard.
As an international business development consultant with special emphasis on Europe and Japan, Kulas spearheaded the
establishment of United States operations for two foreign medical products companies. The driving force behind 23 major
product introductions, Kulas piloted the ``user design team'' concept and has supervised clinical research, regulatory submissions and product development activities domestically and in Canada, Europe and Japan. He is named on one patent and two patents pending.

``MDI is delighted to welcome Lee Kulas as its president and chief executive officer. His vision and his demonstrated knowledge of the medical products industry will surely serve the company well as we move toward commercialization of core technologies both domestically and abroad,'' said Marlin Toombs, director. ``We look forward to capitalizing on Lee's leadership, his well-defined sense of purpose and his proven ability to make things happen,'' Toombs said.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext